FCM marker importance for MRD assessment in T‐cell acute lymphoblastic leukemia: An AIEOP‐BFM‐ALL‐FLOW study group report
Cytometry Part A · 2024-01 · 105 (1) · 24-35
DOI: 10.1002/cyto.a.24805 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cytometry Part A, online erschienen am 19.10.2023. Verfasst von Florian Kowarsch und 13 weiteren Autor:innen. Beteiligte Einrichtung: Computer Vision Lab, Faculty of Informatics, Technical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Vienna Business Agency, Wirtschaftsagentur Wien.
Abstract (Originalsprache)
T‐lineage acute lymphoblastic leukemia (T‐ALL) accounts for about 15% of pediatric and about 25% of adult ALL cases. Minimal/measurable residual disease (MRD) assessed by flow cytometry (FCM) is an important prognostic indicator for risk stratification. In order to assess the MRD a limited number of antibodies directed against the most discriminative antigens must be selected. We propose a pipeline for evaluating the influence of different markers for cell population classification in FCM data. We use linear support vector machine, fitted to each sample individually to avoid issues with patient and laboratory variations. The best separating hyperplane direction as well as the influence of omitting specific markers is considered. Ninety‐one bone marrow samples of 43 pediatric T‐ALL patients from five reference laboratories were analyzed by FCM regarding marker importance for blast cell identification using combinations of eight different markers. For all laboratories, CD48 and CD99 were among the top three markers with strongest contribution to the optimal hyperplane, measured by median separating hyperplane coefficient size for all samples per center and time point (diagnosis, Day 15, Day 33). Based on the available limited set tested (CD3, CD4, CD5, CD7, CD8, CD45, CD48, CD99), our findings prove that CD48 and CD99 are useful markers for MRD monitoring in T‐ALL. The proposed pipeline can be applied for evaluation of other marker combinations in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Computer Vision Lab, Faculty of Informatics, Technical University of Vienna, Vienna, Austria.
- Immunological Diagnostics, St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.
- Labdia Labordiagnostik GmbH, Vienna, Austria.
- The Rina Zaizov Division of Pediatric Hematology-Oncology, Schneider's Children's Medical Center, Petah Tikva, Israel.
- M. Tettamanti Foundation Research Center, Department of Pediatrics, University of Milano-Bicocca, Monza, Italy.
- Department of Pediatric Haematology and Oncology, University Hospital Motol, Prague, Czech Republic.
ORCID-Profile: Florian Kowarsch, Matthias Wödlinger, Michael Reiter, Simona Sala, Michaela Nováková, Giuseppe Gaipa
Förderung
- Vienna Business Agency
- Wirtschaftsagentur Wien
Zitieren
APA
Kowarsch, F., Maurer-Granofszky, M., Weijler, L., Wödlinger, M., Reiter, M., Schumich, A., Feuerstein, T., Sala, S., Nováková, M., Faggin, G., Gaipa, G., Hrusak, O., Buldini, B., & Dworzak, M. N. (2024). FCM marker importance for MRD assessment in T‐cell acute lymphoblastic leukemia: An AIEOP‐BFM‐ALL‐FLOW study group report. Cytometry Part A, 105(1), 24-35. https://doi.org/10.1002/cyto.a.24805
Vancouver
Kowarsch F, Maurer-Granofszky M, Weijler L, Wödlinger M, Reiter M, Schumich A, et al. FCM marker importance for MRD assessment in T‐cell acute lymphoblastic leukemia: An AIEOP‐BFM‐ALL‐FLOW study group report. Cytometry Part A. 2024;105(1):24-35. doi:10.1002/cyto.a.24805
BibTeX
@article{Kowarsch2024,
author = {Kowarsch, Florian and Maurer-Granofszky, Margarita and Weijler, Lisa and Wödlinger, Matthias and Reiter, Michael and Schumich, Angela and Feuerstein, Tamar and Sala, Simona and Nováková, Michaela and Faggin, Giovanni and Gaipa, Giuseppe and Hrusak, Ondrej and Buldini, Barbara and Dworzak, Michael N},
title = {FCM marker importance for MRD assessment in T‐cell acute lymphoblastic leukemia: An AIEOP‐BFM‐ALL‐FLOW study group report},
journal = {Cytometry Part A},
year = {2024},
volume = {105},
number = {1},
pages = {24--35},
doi = {10.1002/cyto.a.24805}
}
EUVIMED